Vande Bharat Mission, US ignored warnings and more: A round-up of the top stories

A brief look at all the news you need to start the day with during the time of social distancing. Follow live updates on COVID-19 here.

An SDMC worker sanitizes a liquor shop at Vasant Vihar in New Delhi. (Photo by Biplov Bhuyan/Hindustan Times via Getty Images)

India readies ‘Vande Bharat Mission’ to bring back stranded nationals

More than three lakh Indians in Gulf countries have registered for evacuation but the government will bring back people on a priority basis. Read More

Govt hikes excise duty on petrol by Rs 10 a litre, diesel by Rs 13 a litre

However, retail sale prices of fuel will not change on account of this increase in duties as the hike will be absorbed by oil marketing companies. Read More

Hacker finds ‘security issue’ in Aarogya Setu app, alerts govt

The hacker, who had found flaws in the Aadhar app, alleges that this issue puts the data of 90 million users at risk. Read More

Trump admin ignored COVID-19 warnings, alleges fired US scientist

Rick Bright alleged that top officials of the Department of Health and Human Services repeatedly ignored his messages and that of others with regard to personal protective equipment and medicines like hydroxychloroquine in particular. Read More

Security forces launch massive searches to nab Hizbul chief in J&K's Pulwama

Riyaz Naikoo took over as the commander of Hizbul Mujahideen after Burhan Wani was killed in a gunfight with the security forces in Kokarnag area in Anantnag district on July 8, 2016. Read More

IPL without foreign players? Delhi Capitals and Rajasthan are game

The 2020 edition of the T20 league was supposed to get underway on 28 March but the nationwide lockdown announced earlier in the month has forced the BCCI to postpone the season indefinitely. Read More

Gilead negotiating licenses with drug makers in India, Pakistan

Gilead Sciences Inc said it was in discussions with chemical and drug manufacturers to produce its experimental COVID-19 drug remdesivir for Europe, Asia and the developing world through at least 2022. Read More